1. P066 ON104, a novel bioengineered antibody targeting oxidized Macrophage Migration Inhibitory Factor (oxMIF) shows efficacy in two distinct models of experimental colitis. (30th January 2023) Authors: Ferhat, M; Mangano, K; Nicoletti, F; Landlinger, C; Michael, T Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i233 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗